GSK boss Andrew Witty discusses Brexit
Media playback is unsupported on your device
Video

GlaxoSmithKline boss: 'Nothing has changed' since Brexit vote

British pharmaceutical giant GlaxoSmithKline was hitting the headlines for all the wrong reasons two years ago.

The business in China was found guilty of bribing doctors to promote its drugs. GSK was fined and several of its staff jailed. The company now claims to have done more than any other to improve compliance.

Next year, GSK chief executive Andrew Witty will retire and he says between now and then making medicines affordable in poorer countries is one of his top priorities.

He also discussed the impact of Brexit and his pay package with the BBC's Sharanjit Leyl.

  • 19 Sep 2016